Major League Baseball Eyes Potential Partnership Following CorVive’s Recent NSF International Certification
PLANO, TX / ACCESSWIRE / September 7, 2023 / Within hours of the public announcement of CorVive's Cor Hydrate Electrolyte...
News
Inovalon’s Cloud-Based Data Platform Rated #1 by Health Plan and Payer Clients for 3rd Consecutive Year, 2023 Black Book Survey
TAMPA, FL / ACCESSWIRE / September 7, 2023 / Black Book Research announced Inovalon has once again been named the...
Uncover Mental Health Counseling Marks 4 Years of Transformative Impact
Uncover Mental Health Counseling, founded by Kristie Tse, stands as a leading mental health practice in NYC that prioritizes inclusivity,...
Neil Lathangue Appointed President of DCS Global
DCS launches new service to save money and improve ESG performanceSupporting building owners, operators, facility and property managementToronto, Ontario--(Newsfile Corp....
Cardio Diagnostics Holdings, Inc. and Truckers Health Network Enter Into a Strategic Collaboration to Accelerate Cardiovascular Health Initiatives in the Trucking Industry
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), a pioneer of artificial intelligence-driven precision cardiovascular medicine tests, today announced a strategic...
As Football Season Kicks Off, ZetrOZ Systems Can Aid Injury Healing
Sustained acoustic medicine provides proven soft tissue healing via ZetrOZ's patented wearable ultrasound unitTRUMBULL, CT / ACCESSWIRE / September 7,...
CNS Pharmaceuticals (NASDAQ: CNSP) Reaches Milestone with Enrollment of 200 Patients in Ongoing Potentially Pivotal Study of Berubicin with the Treatment of Glioblastoma Multiforme (GBM)
Completion of enrollment of study on track by end of 2023Topline data results from interim analysis also on track to...
Jaguar Health’s Executive VP Dr. Karen Brunke Joins BIO’s Rare Disease and Orphan Drugs Committee
Jaguar is supporting investigator-initiated proof-of-concept studies of crofelemer for the rare disease indications of short bowel syndrome and microvillus inclusion...
Fortifeye Vitamins Introduces rTG Omgea 3 Fish Oil, a Revolutionary Leap Forward in Nutritional Health
Fortifeye Vitamins - Introducing rTG Omega 3 Fish OilOCALA, FL / ACCESSWIRE / September 7, 2023 / In a groundbreaking...
Infirmary Health Adopts Wellbox Chronic Care Management, Expanding Patient Access to Virtual Care
JACKSONVILLE, FL / ACCESSWIRE / September 7, 2023 / Wellbox, a population health company focused on improving outcomes in chronically...
Nanoflex Robotics AG Honored with TOP 100 Swiss Startup Award
ZURICH, SWITZERLAND / ACCESSWIRE / September 7, 2023 / Nanoflex Robotics AG, a surgical robotic startup based in Switzerland announced...
Canopus BioPharma Inc., dba Blue Heaven Coffee Inc., Announces PepsiCo Distributor Partnership Beverage Agreement
LAS VEGAS, NV / ACCESSWIRE / September 7, 2023 / Operating as Blue Heaven Coffee Inc. (BHC), Canopus Biopharma Inc....
Eloxx Pharmaceuticals Provides Program Updates on ELX-02 and ZKN-013
Investigational New Drug (IND) application submitted to U.S. Food and Drug Administration (FDA) for ELX-02 for the treatment of Alport...
Lexicon Announces Series of Presentations Relating to LX9211, Its Investigational Drug for the Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)
Five upcoming scientific presentations will add to the body of evidence supporting the advancement of LX9211 into late-stage development Phase...
Sorrento Therapeutics Announces Positive Phase 2a Clinical Trial Results for Resiniferatoxin (RTX) for the Treatment of Knee Pain in Moderate to Severe Osteoarthritis of the Knee (OAK) Patients
Table 1 Table 1 Chart 1 Chart 1 Chart 2 Chart 2 Table 2 Table 2All study objectives were met,...
Oncternal Therapeutics Announces its Prostate Cancer Scientific Advisory Board
SAN DIEGO, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the...
Ocuphire Pharma to Present at ESCRS 2023 and MODLive! Conferences in September
ESCRS presentations will feature clinical data on APX3330 in diabetic retinopathy; Nyxol® data in presbyopia, dim light vision disturbance and...
BiomX to Present Data from Ongoing Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis at the European Respiratory Society (ERS) International Congress 2023
CAMBRIDGE, Mass. and NESS ZIONA, Israel, Sept. 07, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the...
INmune Bio Inc. to Present at Baird Global Healthcare Conference and H.C Wainwright 25th Annual Global Investment Conference
Boca Raton, FL, Sept. 07, 2023 (GLOBE NEWSWIRE) -- INmune Bio (NASDAQ: INMB), a clinical-stage immunology company focused on developing...
HeartSciences Signs Distribution Agreement with MedPhy Technologies, Mumbai, India
Southlake, TX, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"),...